Journal article

Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis

L Roberts, GJ McColl

Internal Medicine Journal | WILEY | Published : 2004

DOI: 10.1111/j.1445-5994.2004.00710.x

University of Melbourne Researchers

Citation metrics

49Web of Science
55Scopus

Keywords

Ankylosing-Spondylitis
Medicine, General & Internal
Humans
Tnf
Treatment Outcome
Chimeric Monoclonal-Antibody
Tumor Necrosis Factors
Concomitant Methotrexate
Science & Technology
Adalimumab
Clinical Trials As Topic
Tuberculosis
Factor-Alpha
Infliximab
Tumor Necrosis Factor Inhibitors
Life Sciences & Biomedicine
Risk Assessment
Rheumatoid Arthritis
Therapy
Etanercept
Antirheumatic Agents
General & Internal Medicine
Arthritis, Rheumatoid
Efficacy
Combination